Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BLB-01D1 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer. According to...
BLB-01D1 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer. According to...
BLB-01D1 by Bristol-Myers Squibb for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase III for Esophageal Squamous Cell Carcinoma (ESCC). According...
BLB-01D1 by Bristol-Myers Squibb for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase III for Triple-Negative Breast Cancer (TNBC). According to...
BLB-01D1 by Bristol-Myers Squibb for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Transitional (Urothelial) Tract Cancer. According...